Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Petmed Express Inc Stock Research

PETS

10.49USD-0.14(-1.32%)Market Closed
Watchlist

Market Summary

USD10.49-0.14
Market Closed
-1.32%

PETS Alerts

PETS Stock Price

PETS RSI Chart

PETS Valuation

Market Cap

225.0M

Price/Earnings (Trailing)

-65.63

Price/Sales (Trailing)

0.85

EV/EBITDA

131.01

Price/Free Cashflow

13.59

PETS Price/Sales (Trailing)

PETS Profitability

EBT Margin

0.62%

Return on Equity

0.19%

Return on Assets

0.14%

Free Cashflow Yield

7.36%

PETS Fundamentals

PETS Revenue

Revenue (TTM)

264.9M

Revenue Y/Y

11.48%

Revenue Q/Q

25.38%

PETS Earnings

Earnings (TTM)

-3.4M

Earnings Y/Y

-131.96%

Earnings Q/Q

82.61%

Price Action

52 Week Range

10.4622.64
(Low)(High)

Last 7 days

-8.8%

Last 30 days

-5.7%

Last 90 days

-23.2%

Trailing 12 Months

-44.5%

PETS Financial Health

Current Ratio

3.6

PETS Investor Care

Dividend Yield

11.29%

Dividend/Share (TTM)

1.2

Shares Dilution (1Y)

4.76%

Diluted EPS (TTM)

-0.16

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for PETS

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-08-14
Smith Jacqueline Paula
acquired
-
-
6,000
-
2023-08-03
FULGONI GIAN
acquired
-
-
7,500
-
2023-08-03
Campbell Leslie C.G.
acquired
-
-
7,500
-
2023-08-03
Campos Sandra Yvette
acquired
-
-
7,500
-
2023-08-03
PURCEL DIANA G
acquired
-
-
7,500
-
2023-06-15
Chambers Christine
acquired
-
-
11,750
cfo
2023-06-08
Chambers Christine
back to issuer
-
-
-3,000
cfo
2023-05-17
Moseley Mark Bradley JR
acquired
216,720
15.48
14,000
-
2023-05-17
Pingree Daniel Job
acquired
170,280
15.48
11,000
-
2022-07-28
FULGONI GIAN
acquired
163,200
21.76
7,500
-

1–10 of 50

Which funds bought or sold PETS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-20
BARCLAYS PLC
added
105
608,000
1,426,000
-%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
reduced
-88.56
-96,000
10,000
-%
2023-08-21
OSAIC HOLDINGS, INC.
added
6.43
-20,865
195,698
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
added
1.25
-57,103
350,018
-%
2023-08-16
Nuveen Asset Management, LLC
unchanged
-
-146,096
822,904
-%
2023-08-15
GOLDMAN SACHS GROUP INC
added
33.03
389,502
3,394,970
-%
2023-08-15
WELLS FARGO & COMPANY/MN
added
28.74
15,255
179,211
-%
2023-08-15
CONNORS INVESTOR SERVICES INC
added
3.04
-327,000
2,287,000
0.26%
2023-08-15
Belpointe Asset Management LLC
sold off
-100
-430
-
-%
2023-08-15
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
added
5.01
-1,000
10,000
-%

1–10 of 43

Latest Funds Activity

Are funds buying PETS calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own PETS
No. of Funds

Schedule 13G FIlings of Petmed Express

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jul 07, 2023
blackrock inc.
8.0%
1,694,462
SC 13G/A
Feb 09, 2023
vanguard group inc
7.04%
1,483,238
SC 13G/A
Jan 26, 2023
proshare advisors llc
3.2%
649,277
SC 13G/A
Jan 23, 2023
blackrock inc.
16.5%
3,473,358
SC 13G/A
Jan 27, 2022
blackrock inc.
15.7%
3,290,803
SC 13G/A
Jan 26, 2022
blackrock inc.
15.7%
3,290,803
SC 13G
Feb 11, 2021
renaissance technologies llc
6.21%
1,258,073
SC 13G/A
Feb 10, 2021
vanguard group inc
7.74%
1,569,843
SC 13G/A
Jan 25, 2021
blackrock inc.
15.4%
3,131,671
SC 13G
Feb 13, 2020
renaissance technologies llc
8.02%
1,616,400
SC 13G/A

Recent SEC filings of Petmed Express

View All Filings
Date Filed Form Type Document
Aug 30, 2023
S-8 POS
Employee Benefits Plan
Aug 30, 2023
S-8 POS
Employee Benefits Plan
Aug 28, 2023
S-8 POS
Employee Benefits Plan
Aug 28, 2023
S-8 POS
Employee Benefits Plan
Aug 16, 2023
4
Insider Trading
Aug 16, 2023
4
Insider Trading
Aug 04, 2023
4
Insider Trading
Aug 04, 2023
4
Insider Trading
Aug 04, 2023
4
Insider Trading
Aug 04, 2023
4
Insider Trading

Peers (Alternatives to Petmed Express)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
1.3T
538.0B
-5.46% 9.41%
99.39
2.41
10.73% 12.62%
22.9B
9.9B
-0.23% 14.06%
17.05
2.3
-0.79% 271.47%
7.6B
2.7B
-14.44% -34.39%
-10.64
2.86
9.87% -816.12%
7.6B
10.8B
-31.37% -44.84%
152.87
0.7
14.19% 190.02%
MID-CAP
6.4B
11.9B
-12.78% 59.14%
-6.15
0.54
-6.04% -5.94%
SMALL-CAP
948.1M
1.1B
-11.76% -46.19%
22.94
0.88
2.25% -51.31%
737.2M
1.7B
-34.05% -30.12%
-5.41
0.44
-29.49% -269.03%
404.1M
1.6B
-5.15% -11.17%
-2.35
0.25
-20.96% 16.97%
239.4M
1.5B
-18.56% -6.98%
-13.56
0.16
-3.31% -277.23%
225.0M
264.9M
-5.68% -44.53%
-65.63
0.85
0.24% -117.63%
210.4M
575.1M
-11.97% 35.53%
-1
0.37
1.77% 4.67%
189.3M
651.8M
-22.33% -19.69%
-40.77
0.29
-4.22% -121.89%
6.5M
-
-42.26% -92.03%
-0.15
0.01
- -

Petmed Express News

Best Stocks
Mixed Sentiment in CVS Health Options Activity.
Best Stocks,
3 hours ago
Seeking Alpha

Returns for PETS

Cumulative Returns on PETS

-0.5%


10-Year Cumulative Returns

-5.6%


7-Year Cumulative Returns

-17.9%


5-Year Cumulative Returns

-27.5%


3-Year Cumulative Returns

Risks for PETS

What is the probability of a big loss on PETS?

95.8%


Probability that Petmed Express stock will be more than 20% underwater in next one year

65.4%


Probability that Petmed Express stock will be more than 30% underwater in next one year.

28.1%


Probability that Petmed Express stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does PETS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Petmed Express was unfortunately bought at previous high price.

Drawdowns

Financials for Petmed Express

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue3.1%265257260262264273279284292309312306300284274275276283286286282
Gross Profit3.6%74.0071.0073.0076.0076.0078.0079.0081.0085.0090.0091.0089.0086.0081.0080.0082.0087.0095.00100102100
Operating Expenses11.3%81.0072.0060.0057.0052.0052.0052.0050.0051.0052.0053.0053.0052.0050.0050.0050.0051.0049.0047.0048.0047.00
  S&GA Expenses12.9%56.0049.0039.0036.0032.0031.0030.0029.0029.0028.0027.0027.0027.0025.0025.0024.0024.0025.0025.0025.0025.00
EBITDA-100.0%-5.0018.0023.0028.0030.0031.0035.0038.0039.0039.0038.0037.0034.0033.00------
EBITDA Margin-100.0%-0.02*0.07*0.09*0.11*0.11*0.11*0.12*0.13*0.13*0.13*0.13*0.12*0.12*0.12*------
Earnings Before Taxes-303.5%-3.222.0015.0020.0025.0027.0028.0033.0035.0039.0039.0038.0037.0034.0033.0035.0040.0049.0055.0057.0056.00
EBT Margin-100.0%-0.01*0.06*0.08*0.09*0.10*0.10*0.11*0.12*0.13*0.13*0.13*0.12*0.12*0.12*------
Net Income-1571.7%-3.430.0011.0016.0019.0021.0022.0025.0027.0031.0031.0030.0028.0026.0025.0026.0031.0038.0041.0043.0041.00
Net Income Margin-100.0%-0.00*0.04*0.06*0.07*0.08*0.08*0.09*0.09*0.10*0.10*0.10*0.09*0.09*0.09*------
Free Cashflow-100.0%-23.0023.0019.0023.0017.0026.0024.0048.0038.0037.0034.0025.0037.0033.00------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets10.1%181164165169165176168159173187167159163155150146145154157148153
  Current Assets-19.5%106131134138134151143133147161141133136129123118117126128119123
    Cash Equivalents-40.9%62.0010410297.0010511110910711211910710687.0010492.0095.0083.0010193.0087.0095.00
  Net PPE3.9%27.0026.0025.0025.0025.0024.0025.0025.0025.0025.0026.0025.0026.0025.0026.0026.0027.0027.0028.0028.0028.00
  Goodwill-21.00--------------------
Liabilities54.8%62.0040.0032.0031.0025.0034.0028.0018.0033.0046.0028.0023.0030.0025.0022.0020.0021.0020.0024.0018.0029.00
  Current Liabilities57.1%57.0036.0031.0031.0024.0033.0026.0016.0032.0045.0027.0021.0029.0024.0021.0019.0020.0019.0023.0017.0028.00
Shareholder's Equity-4.4%118124134138140142141141140141139136133130128126124135133130124
  Retained Earnings-6.9%98.00105117123127130131133132134133131128126125123122122121119114
  Additional Paid-In Capital9.6%20.0018.0017.0015.0013.0012.0010.009.008.007.006.005.005.004.003.002.002.0012.0012.0011.0010.00
Shares Outstanding0.4%21.0021.0021.0021.0020.0021.0020.0020.0020.0020.0020.0020.0020.0020.0020.0020.0020.0021.0020.0020.0020.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations-20.9%22.0028.0027.0023.0025.0018.0028.0026.0051.0040.0039.0037.0028.0039.0035.0042.0023.0045.0034.0039.0046.00
  Share Based Compensation3.4%7.007.006.006.005.005.004.003.003.003.003.003.003.003.003.003.003.003.003.003.003.00
Cashflow From Investing-302.4%-41.29-10.26-8.81-8.12-7.26-1.75-1.85-2.21-2.76-2.43-2.33-3.09-2.26-2.31-1.94-0.59-0.51-0.62-0.65-0.80-0.97
Cashflow From Financing-0.2%-24.57-24.54-24.46-24.43-24.41-24.38-23.97-23.53-23.13-22.69-22.43-22.20-21.92-33.30-33.54-33.68-33.80-21.92-21.44-19.99-18.51
  Dividend Payments0.2%25.0025.0024.0024.0024.0024.0024.0024.0023.0023.0022.0022.0022.0022.0022.0022.0022.0022.0021.0020.0019.00
  Buy Backs-----------0.000.000.0011.0015.0023.0046.00----

PETS Income Statement

2023-06-30
Condensed Consolidated Statements of (Loss) Income - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]  
Sales$ 78,244$ 70,187
Cost of sales55,71850,244
Gross profit22,52619,943
Operating expenses:  
General and administrative15,7119,351
Advertising7,2656,349
Depreciation and amortization1,678753
Total operating expenses24,65416,453
(Loss) income from operations(2,128)3,490
Other income:  
Interest income, net620117
Other, net506198
Total other income1,126315
(Loss) income before (benefit) provision for income taxes(1,002)3,805
(Benefit) provision for income taxes(115)1,030
Net (loss) income$ (887)$ 2,775
Net (loss) income per common share:  
Basic (in dollars per share)$ (0.04)$ 0.14
Diluted (in dollars per share)$ (0.04)$ 0.14
Weighted average number of common shares outstanding:  
Basic (in shares)20,33320,208
Diluted (in shares)20,33320,291
Cash dividends declared per common share (in dollars per share)$ 0.30$ 0.30

PETS Balance Sheet

2023-06-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Mar. 31, 2023
Current assets:  
Cash and cash equivalents$ 61,534$ 104,086
Accounts receivable, less allowance for doubtful accounts of $38 and $35, respectively1,8941,740
Inventories - finished goods32,32419,023
Prepaid expenses and other current assets8,5304,719
Prepaid income taxes1,5481,883
Total current assets105,830131,451
Noncurrent assets:  
Property and equipment, net27,20726,178
Intangible and other assets, net17,6715,860
Goodwill20,7350
Operating lease right-of-use assets, net2,0240
Deferred tax assets, net7,270628
Total noncurrent assets74,90732,666
Total assets180,737164,117
Current liabilities:  
Accounts payable40,03725,208
Accrued expenses and other current liabilities13,24011,289
Current lease liabilities7990
Deferred revenue3,2460
Total current liabilities57,32236,497
Long-term lease liabilities1,2680
Other long-term liabilities3,8253,825
Total liabilities62,41540,322
Commitments and contingencies (Note 9)
Shareholders' equity:  
Preferred stock, $.001 par value, 5,000 shares authorized; 3 convertible shares issued and outstanding with a liquidation preference of $4 per share99
Common stock, $.001 par value, 40,000 shares authorized; 21,170 and 21,084 shares issued and outstanding, respectively2121
Additional paid-in capital20,03718,277
Retained earnings98,255105,488
Total shareholders' equity118,322123,795
Total liabilities and shareholders' equity$ 180,737$ 164,117
Matthew N. Hulett
220
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website and mobile app; telephone contact center; and direct mail/print through catalogs, brochures, and postcards. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.